Lung Cancer Trial, Recruiting NCT07681245 Sponsor: Shanghai Chest Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07681245
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Imaging results (such as a CT scan) show a lung nodule, growth, or suspected tumour in the lung.
  • The person is already scheduled to have lung surgery, such as removal of a small section, segment, or lobe of the lung.
  • A fresh sample of lung tissue can be collected during the surgery for use with a special laser imaging technique.
  • A quick tissue analysis (called a frozen section) is planned during the surgery to help assess the tissue.
  • A standard detailed tissue analysis (using paraffin-embedded pathology) can be carried out after surgery.
  • The person, or their legally authorised representative, has signed a consent form agreeing to take part.

Who may not be able to join:

  • The tissue sample collected during surgery is too small to be used for both standard clinical testing and the research procedures at the same time.
  • The tissue sample is too damaged — for example, due to burning, decay, crushing, contamination, or poor storage — and the investigator determines that useful imaging cannot be done.
  • The laser-imaged tissue sample cannot be matched to the same area of tissue examined in the final detailed pathology report.
  • A final detailed pathology report (paraffin-embedded) cannot be obtained after surgery.
  • The person withdraws their consent to take part.
  • The investigator determines, for any other reason, that the person is not suitable for this study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 17701681215

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Chest Hospital
Registry
ClinicalTrials.gov
Start date
3 July 2026
Est. completion
30 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Non-inferiority performance threshold

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov